Home » Centers of Excellence » Cell and Gene Therapy

Cell and Gene Therapy

Cell and gene therapies represent a fundamental therapeutic revolution. CBPartners’ Center of Excellence focuses on assessing the unique opportunities and challenges associated with the emerging class of novel treatments. With a lens towards identifying key value, access, and pricing dynamics, our team can determine the influence these innovative treatments will have when entering the market.

Questions that our clients ask

  • How will non-cell and gene therapies competing within a given disease space impact payer and provider perceptions of a cell / gene therapy’s value?
  • How can we best differentiate our value proposition and corresponding launch strategy?
  • What evidence should be developed to support the unique value proposition of cell and gene therapies, given some of the inherent limitations such as single-arm trial, short follow-up?
  • How can alternative payment models be leveraged to gain access and optimize pricing?
  • How will the unique one-time administration feature, paired with a significant upfront price point, impact access and utilization?
  • How can we navigate the reimbursement implications of inpatient cell or gene therapy administration (particularly for Medicare and Medicaid patients) to minimize provider-level financial exposure and ensure hospitals receive sufficient payment for treatment?

Specialist therapeutic areas

Oncology cell therapies and rare disease gene therapies.

Specialized markets

The CBP difference

  • We help clients to navigate this rapidly evolving landscape
  • We think outside the box and customize strategies while being a partner throughout the process
  • We use targeted recruitment to ensure we reach the right stakeholders